Advertisement

Topics

India's top 100 pharma cos post single digit growth in sales & profit during 2016─17

09:24 EDT 9 Aug 2017 | PharmaBiz

The financial performances of top 100 listed pharmaceutical companies was badly impacted adversely during the year ended March 2017 on account of quality problems with US FDA, price cuts by governments in domestic and international markets

Original Article: India's top 100 pharma cos post single digit growth in sales & profit during 2016─17

NEXT ARTICLE

More From BioPortfolio on "India's top 100 pharma cos post single digit growth in sales & profit during 2016─17"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...